ライフサイエンスコーパス: estrogen receptor antagonist

1 enol red-free media or in the presence of an estrogen receptor antagonist.

2 ot blocked by ICI182780 (50 micro mol/L), an estrogen receptor antagonist.

3 Fulvestrant is a selective estrogen receptor antagonist.

4 This protective effect was abrogated by an estrogen-receptor antagonist.

5 ive effect of E2 was nullified by a specific estrogen-receptor antagonist.

6 mented estrogenic responses not inhibited by estrogen receptor antagonists.

7 The endogenous estrogen receptor antagonist 27-hydroxycholesterol (27OH

8 Estrogen receptor antagonists 4-hydroxytamoxifen and 7al

9 he presence of beta-estradiol as well as the estrogen-receptor antagonist 4-Hydroxy-Tamoxifen and the

10 bited through light-dependent release of the estrogen receptor antagonist, 4-hydroxycyclofen.

11 eliminated by ICI 182,780 (10(-7) mol/L), an estrogen receptor antagonist; 5, 6-dichloro-1-beta-D-rib

12 estrogen receptor because addition of a pure estrogen receptor antagonist abrogated this effect.

13 AZD9496 is an oral, nonsteroidal, selective estrogen receptor antagonist and downregulator in ER(+)

14 ential chemopreventive activity of selective estrogen-receptor antagonists as chemopreventives for br

15 Estrogen receptor antagonists blocked the synergistic in

16 Topical treatments with ICI 182,780, a pure estrogen receptor antagonist, caused the hair follicles

17 trogen receptor modulator that is used as an estrogen receptor antagonist for the treatment and preve

18 Moreover, the estrogen receptor antagonist fulvestrant (ICI 182,780) d

19 This effect was blocked by the estrogen receptor antagonist fulvestrant (ICI-182,780, F

20 revent masculine development through various estrogen receptor antagonists have been relatively ineff

21 The estrogen receptor antagonist ICI 164384 had no effect on

22 the PI3-kinase inhibitor, LY294002, and the estrogen receptor antagonist ICI 182, 780.

23 These effects were inhibited by the estrogen receptor antagonist ICI 182,780 but could be pr

24 In vitro, concurrent treatment with the estrogen receptor antagonist ICI 182,780 rescued TH-ir c

25 s of estradiol are completely blocked by the estrogen receptor antagonist ICI 182,780, and the intrac

26 variectomized mice, and was prevented by the estrogen receptor antagonist ICI 182,780.

27 echol estrogens, but not by 17beta-E2 or the estrogen receptor antagonist ICI 182,780.

28 ability, an effect partially reversed by the estrogen receptor antagonist ICI 182,780.

29 and completely inhibited by the conventional estrogen receptor antagonist ICI 182,780.

30 f wild-type cultures, was not blocked by the estrogen receptor antagonist ICI 182,780.

31 ibited by the antiestrogen tamoxifen and the estrogen receptor antagonist ICI 182,780.

32 nificantly attenuated in the presence of the estrogen receptor antagonist ICI-182780.

33 retreatment with indomethacin or the classic estrogen-receptor antagonist ICI 182,780 did not alter t

34 oprotective effects of E2 were blocked by an estrogen receptor antagonist (ICI 182,780) and by a Trx

35 Estrogen, with or without an estrogen receptor antagonist (ICI 182,780), a PI3K inhib

36 diol-BSA; 1 mg/kg estradiol) with or without estrogen receptor antagonist (ICI 182,780), PI3K inhibit

37 pansion in culture was blocked by a specific estrogen receptor antagonist (ICI 182,780).

38 The estrogen receptor antagonist, ICI 182,780, did not block

39 This effect was blocked by the estrogen receptor antagonist, ICI 182,780, indicating th

40 e estrogen receptor, and the addition of the estrogen receptor antagonist, ICI 182,780, to influence

41 H was not antagonized by the addition of the estrogen receptor antagonist, ICI 182,780.

42 An estrogen receptor antagonist, ICI-182,780, or E2 failed

43 ression was inhibited in the presence of the estrogen receptor antagonist, ICI-182780.

44 We observed that a specific estrogen receptor antagonist (ICI182780) was able to pre

45 port the hypothesis that ICI is an effective estrogen receptor antagonist in the zebra finch brain an

46 ovariectomy or treating female mice with an estrogen receptor antagonist increased mortality, indica

47 ce was eliminated after pretreatment with an estrogen receptor antagonist or ovariectomy but restored

48 single intracerebroventricular injection of estrogen receptor antagonists or aromatase inhibitors, r

49 vessels with 17beta-E2 plus ICI, 182,780, an estrogen receptor antagonist, or wortmannin, an inhibito

50 eptor and mediates the inhibitory effects of estrogen receptor antagonists, such as tamoxifen, suppre

51 Addition of the estrogen receptor antagonist tamoxifen did not reverse t

52 at were previously reported as non-steroidal estrogen receptor antagonists with in vitro and in vivo

53 xifen and in designing screens to select for estrogen-receptor antagonists without these side effects

54 ion; this effect was blocked by the specific estrogen receptor antagonist ZK-119.010.